Literature DB >> 1505057

A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene.

J Odum1, J R Foster, T Green.   

Abstract

Female CD-1 mice exposed to trichloroethylene (6 h/day) at concentrations from 20-2000 ppm developed a highly specific lung lesion after a single exposure, characterised by vacuolation of the Clara cells, the number of cells affected increasing with increasing dose level. At the highest dose levels pyknosis of the Clara cells was apparent. After 5 days of repeated exposures the lesion had resolved but exposure of mice following a 2-day break resulted in recurrence of the lesion. The changes in mouse lung Clara cells were accompanied by a marked loss of cytochrome P-450 activities. No morphological changes were seen in the lungs of rats exposed to either 500 or 1000 ppm trichloroethylene. Isolated mouse lung Clara cells were shown to metabolize trichloroethylene to chloral, trichloroethanol and trichloroacetic acid. Chloral was the major metabolite. Trichloroethanol glucuronide was not detected. In comparative experiments using mouse hepatocytes the major metabolites were trichloroethanol and its glucuronide conjugate. The activity of UDP-glucuronosyltransferase was compared in mouse lung Clara cells and hepatocytes using two phenolic substrates and trichloroethanol. Hepatocytes readily formed glucuronides from all three substrates whereas Clara cells were only active with the two phenolic substrates. The three major metabolites of trichloroethylene, chloral, trichloroethanol and trichloroacetic acid were each dosed to mice and of these metabolites, only chloral had an effect on mouse lung causing a lesion (Clara cell) identical to that seen with trichloroethylene. It is proposed that the failure of Clara cells to conjugate trichloroethanol leads to an accumulation of chloral which results in cytotoxicity. The known genotoxicity of chloral suggests that this lesion may be related to the development of lung tumours in mice exposed to trichloroethylene by inhalation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505057     DOI: 10.1016/0009-2797(92)90042-j

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  15 in total

1.  Placenta as a target of trichloroethylene toxicity.

Authors:  Elana R Elkin; Sean M Harris; Anthony L Su; Lawrence H Lash; Rita Loch-Caruso
Journal:  Environ Sci Process Impacts       Date:  2020-02-05       Impact factor: 4.238

Review 2.  Cancer in relation to occupational exposure to trichloroethylene.

Authors:  N S Weiss
Journal:  Occup Environ Med       Date:  1996-01       Impact factor: 4.402

3.  Spatiotemporal changes of CVOC concentrations in karst aquifers: analysis of three decades of data from Puerto Rico.

Authors:  Xue Yu; Reza Ghasemizadeh; Ingrid Padilla; Celys Irizarry; David Kaeli; Akram Alshawabkeh
Journal:  Sci Total Environ       Date:  2014-12-16       Impact factor: 7.963

Review 4.  Comparative pathobiology of environmentally induced lung cancers in humans and rodents.

Authors:  Arun Pandiri
Journal:  Toxicol Pathol       Date:  2014-10-27       Impact factor: 1.902

Review 5.  Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.

Authors:  Lawrence H Lash; Weihsueh A Chiu; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2014 Oct-Dec       Impact factor: 5.657

6.  Formation of covalently bound protein adducts from the cytotoxicant naphthalene in nasal epithelium: species comparisons.

Authors:  Christina DeStefano-Shields; Dexter Morin; Alan Buckpitt
Journal:  Environ Health Perspect       Date:  2010-05       Impact factor: 9.031

Review 7.  Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard.

Authors:  Ivan Rusyn; Weihsueh A Chiu; Lawrence H Lash; Hans Kromhout; Johnni Hansen; Kathryn Z Guyton
Journal:  Pharmacol Ther       Date:  2013-08-23       Impact factor: 12.310

Review 8.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Authors:  H J Clewell; P R Gentry; T R Covington; J M Gearhart
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 9.  Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.

Authors:  H A Barton; H J Clewell
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 10.  Human health effects of trichloroethylene: key findings and scientific issues.

Authors:  Weihsueh A Chiu; Jennifer Jinot; Cheryl Siegel Scott; Susan L Makris; Glinda S Cooper; Rebecca C Dzubow; Ambuja S Bale; Marina V Evans; Kathryn Z Guyton; Nagalakshmi Keshava; John C Lipscomb; Stanley Barone; John F Fox; Maureen R Gwinn; John Schaum; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2012-12-18       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.